Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution.

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Abstract Text:

V T Ramaekers,M ,T Opladen,G Heimann,N Blau,V T Ramaekers,M ,T Opladen,G Heimann,N Blau,

INTRODUCTION: Normal brain development and function depend on the active transport of folates across the blood-brain barrier. The folate receptor-1 (FR 1) protein is localized at the basolateral surface of the choroid plexus, which is characterized by a high binding affinity for circulating 5-methyltetrahydrofolate (5-MTHF). PATIENTS AND METHODS: We report on the clinical and metabolic findings among five children with normal neurodevelopmental progress during the first four to six months followed by the acquisition of a neurological condition which includes marked irritability, decelerating head growth, psychomotor retardation, cerebellar ataxia, dyskinesias (choreoathetosis, ballism), pyramidal signs in the lower limbs and occasional seizures. After the age of six years the two oldest patients also manifested a central visual disorder. Known disorders have been ruled out by extensive investigations. Cerebrospinal fluid (CSF) analysis included determination of biogenic monoamines, pterins and 5-MTHF. RESULTS: Despite normal folate levels in serum and red blood cells with normal homocysteine, analysis of CSF revealed a decline towards very low values for 5-methyltetrahydrofolate (5-MTHF), which suggested disturbed transport of folates across the blood-brain barrier. Genetic analysis of the FR 1 gene revealed normal coding sequences. Oral treatment with doses of the stable compound folinic acid (0.5-1 mg/kg/day Leucovorin(R)) resulted in clinical amelioration and normalization of 5-MTHF values in CSF. CONCLUSION: Our findings identified a new condition manifesting after the age of 6 months which was accompanied by low 5-MTHF in cerebrospinal fluid and responded to oral supplements with folinic acid. However, the cause of disturbed folate transfer across the blood-brain barrier remains unknown.

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Publishing Authors By Initials

VT Ramaekers,M ,T Opladen,G Heimann,N Blau,VT Ramaekers,M ,T Opladen,G Heimann,N Blau,

For similar proteins: transcription factors research abstracts see: proteins: transcription factors research

PUBMED ID PMID:

MEDLINE DATE:

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Neuropediatrics

VOLUME: 33

Page Numbers: 301-8

Journal Abbreviation: Neuropediatrics

ISSN: 0174-304X

DAY: 16

MONTH: Dec

YEAR: 2002

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8101187

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Keywords Mesh Terms:

KEYWORDS: Transcription Factors

MESH TERMS: deficiency

Chemical & Substance for Abstract: Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. Information

Substance Name: Leucovorin

Registry Number: 58-05-9

Grant and Affiliation Information for Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution.

AFFILIATION: Division of Paediatric Neurology, Department of Paediatrics, University Hospital Aachen, Aachen, Germany. vramaekers@ukaachen.de

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neuropediatrics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution Related Publications

• A comparison of NIH-approved human ESC lines.
• A generic organometallic approach toward ultra-strong carbon nanotube polymer composites.
• A novel enzyme complementation-based assay for monitoring G-protein-coupled receptor internalization.
• A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions.
• A universal technology for monitoring G-protein-coupled receptor activation in vitro and noninvasively in live animals.
• Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons.
• Anne McLaren (1927-2007).
• Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures.
• Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
• Cost-benefit assessment of antifungal prophylaxis with liposomal amphotericin B in neutropenic patients.
• Emergency treatment of chest wounds.
• Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
• False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam-is it still an issue?
• Feeling and seeing headaches.
• Growth factor receptors as regulators of hematopoiesis.
• Increased host neuronal survival and motor function in BMT Parkinsonian mice: involvement of immunosuppression.
• Joint hypermobility and headache.
• Localization of vascular response to VEGF is not dependent on heparin binding.
• Membranes, ions, and clocks: testing the njus-sulzman-hastings model of the circadian oscillator.
• Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia.
• Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
• Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis.
• Passive water-lipid Peptide translocators with conformational switches: from single-molecule probe to cellular assay.
• Penetration of colloidal carbon through post-capillary venules in lymph nodes and Peyer's patches of the guinea-pig: a potential immunogeneic route.
• Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution.
• Sleep deprivation headache.
• The cerebrospinal fluid level of 5-methylterahydrofolate in a Japanese boy with hypomyelination with atrophy of the Basal Ganglia and cerebellum.
• [Estrogen and progesterone receptors in mesenchymal structures of the female urogenital tract]
• [Partial denervation of the bladder--last resort in the treatment of motor urge incontinence]
• [The use of a double balloon catheter in the topical extra-amniotic administration of prostaglandin F2alpha gel in indicated labor induction and cervix incompetence]